Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope
1990
Workup and management of patients with syncope
1995
Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures
1995
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Traditional Chinese Medicine for Cardiovascular Disease
2017 Standout
Effect of High Doses of Magnesium on Converting Ibutilide to a Safe and More Effective Agent
2010
Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis
2007
Role of Purkinje Fibers in Post-Infarction Ventricular Tachycardia
2006
Exercise Standards for Testing and Training
2013 Standout
CLINICAL IMPLICATIONS OF ELECTROPHYSIOLOGY STUDY FINDINGS IN PATIENTS WITH CHRONIC BIFASCICULAR BLOCK AND SYNCOPE
1988
Drug-Induced Hepatotoxicity
2003 Standout
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation
2002
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
2008
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Purkinje‐Related Arrhythmias Part I: Monomorphic Ventricular Tachycardias
2011
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Syncope of unknown origin: Clinical, noninvasive, and electrophysiologic determinants of arrhythmia induction and symptom recurrence during long-term follow-up
1991
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
1996 Standout
Myocarditis
2011 Standout
Cure of Interfascicular Reentrant Ventricular Tachycardia by Ablation of the Anterior Fascicle of the Left Bundle Branch
1995
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
2009
Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation
2001
Coordinated induction of iNOS–VEGF–KDR–eNOS after resveratrol consumption
2005
Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
1989
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
1998 Standout
Is syncope a risk factor for poor outcomes? comparison of patients with and without syncope
1996
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
2008
Sudden cardiac death and polymorphous ventricular tachycardia in pationts with normal QT intervals and normal systolic cardiac function
1995
Bcl-2 family members and apoptosis, taken to heart
2006
Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases
2003
Incidence and Prognosis of Syncope
2002 Standout
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantablecardioverter defibrillator therapy
2003
Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin
1988
Serial chest thumps for the treatment of ventricular tachycardia in patients with coronary artery disease
1992
Bundle Branch Reentrant Ventricular Tachycardia:
1993
Post-Infarction Ventricular Arrhythmias Originating in Papillary Muscles
2008
Comparison of Cardiac Pacing with Drug Therapy in the Treatment of Neurocardiogenic (Vasovagal) Syncope with Bradycardia or Asystole
1993
Natural history of patients with unexplained syncope and a nondiagnostic electrophysiologic study
1989
Unexplained Syncope Evaluated by Electrophysiologic Studies and Head-up Tilt Testing
1991
Characteristics of bundle branch reentrant ventricular tachycardia with a right bundle branch block configuration: feasibility of atrial pacing
2009
Myocarditis
2009 Standout
The value of electrophysiologic studies in syncope of undetermined origin: Report of 150 cases
1985
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Ventricular Tachycardia in Valvular Heart Disease
1997
Electrophysiologic testing in bundle branch block and unexplained syncope
1984
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
2006
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract Obstruction
2013
Serial chest thumps for the treatment of ventricular tachycardia in patients with coronary artery disease
1992
Magnesium in Man: Implications for Health and Disease
2014 Standout
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
2009
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Nonreentrant Mechanisms Underlying Spontaneous Ventricular Arrhythmias in a Model of Nonischemic Heart Failure in Rabbits
1995
Apoptosis: A Review of Programmed Cell Death
2007 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Radiofrequency Catheter Ablation of Right Ventricular Tachycardia Late After Repair of Congenital Heart Defects
1996
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Significance of inducible tachycardia in patients with syncope of unknown origin: A long-term follow-up
1985
Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery
1995
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure
1998 Standout
Mapping and Ablation of Idiopathic Ventricular Fibrillation
2002
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function.
1990
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Increased hepatic density and phospholipidosis due to amiodarone
1985
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Brugada Syndrome: Report of the Second Consensus Conference
2005 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Impact of Atrial Fibrillation on the Risk of Death
1998 Standout
Sudden Cardiac Death
1998 Standout
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery
2006
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Electrophysiologic testing in patients with unexplained syncope: Clinical and noninvasive predictors of outcome
1987
CLINICAL GUIDELINE: Diagnosing Syncope: Part 2: Unexplained Syncope
1997
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.
1991
Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice
2003
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Clinical Predictors of Electrophysiologic Findings in Patients With Syncope of Unknown Origin
1988
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Vascular endothelial growth factor (VEGF) and its receptors
1999 Standout
Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope
1985
Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice
2002
Works of Stephen Denker being referenced
Useful clinical criteria for the diagnosis of ventricular tachycardia
1988
Effects of alternating cycle lengths on refractoriness of the His-Purkinje system.
1984
Sustained bundle branch reentry as a mechanism of clinical tachycardia.
1989
Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length
1984
Role of Cardiac Electrophysiologic Studies in Patients with Unexplained Recurrent Syncope
1983
Efficacy and Safety of Ibutilide Fumarate for the Conversion of Atrial Arrhythmias After Cardiac Surgery
1999
Incidence and clinical significance of ventricular fibrillation induced with single and double ventricular extrastimuli
1986
Linking: a dynamic electrophysiologic phenomenon in macroreentry circuits.
1985
Transcatheter electrical ablation of right bundle branch. A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry.
1988
Abnormal abdominal computerized tomography with amiodarone therapy and clinical significance
1984
Effects of abrupt changes in cycle length on refractoriness of the His-Purkinje system in man.
1983
Atrioventricular nodal conduction and refractoriness after intranodal collision from antegrade and retrograde impulses.
1983
Facilitation of macroreentry within the His-Purkinje system with abrupt changes in cycle length.
1984